Glaucoma
Birmingham research paves way for new anti-fibrotic glaucoma treatment
January 8, 2021Medical Communications Glaucoma, University of Birmingham
New research from the University of Birmingham has shown that a novel low molecular weight dextran-sulphate, ILB, could play a …
Aerie’s glaucoma drug gets strong preliminary FDA opinion
October 12, 2017Sales and Marketing Aerie, Aerie Pharmaceutical, FDA, Glaucoma, Rhopressa, pharma
In a preliminary review of the drug, the FDA has judged that Aerie Pharmaceutical’s experimental glaucoma treatment Rhopressa (netarsudil) effectively …
Inotek’s glaucoma lead candidate falls at Phase 3 trial
January 4, 2017Research and Development Glaucoma, inotek, inotek pharma
Inotek Pharmaceutical announced that its lead candidate, trabodenoson, a drug designed to treat glaucoma, had failed to outperform placebos in …
Valeant receives complete response letter from FDA on glaucoma drug
July 22, 2016Medical Communications, Sales and Marketing FDA, Glaucoma, Valeant
Valeant Pharmaceuticals has announced that it has received a complete response letter from the FDA rejecting their new drug application …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
